Literature DB >> 9347863

Isolated upright gastroesophageal reflux is not a contraindication for antireflux surgery.

M Fein1, J A Hagen, M P Ritter, T R DeMeester, M De Vos, C G Bremner, J H Peters.   

Abstract

BACKGROUND: Patients with gastroesophageal reflux disease who reflux only in the upright position are thought to have a less severe abnormality. Controversy exists over whether these patients should be considered candidates for antireflux surgery.
METHODS: A total of 224 consecutive patients with increased esophageal acid exposure on 24-hour pH monitoring were classified as having upright (n = 54), supine (n = 72), or bipositional (n = 98) reflux and were evaluated by manometry and endoscopy. Of these, 116 patients had a laparoscopic Nissen fundoplication. Their clinical outcome at a median of 12 months (range 4 to 44 months) was compared.
RESULTS: Patients with upright reflux had a lower prevalence of a structurally defective lower esophageal sphincter, fewer hiatal hernias, and less esophageal injury when compared to those with bipositional reflux (p < 0.005). Excellent (asymptomatic) or good outcome (minor symptoms not requiring acid suppression therapy) was achieved in 86% of the patients with upright reflux, 90% of those with supine reflux, and 89% of those with bipositional reflux.
CONCLUSIONS: Patients with upright reflux have less complicated, earlier disease and have results equivalent to those patients with supine and bipositional reflux after antireflux surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9347863     DOI: 10.1016/s0039-6060(97)90094-5

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Effect of "white diet" during bile monitoring with Bilitec 2000 on esophageal pH-metry in patients with gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Elfriede Bollschweiler; Wolfgang Schröder; Peter Collet; Jean-Marie Collard; Arnulf H Hölscher
Journal:  J Gastrointest Surg       Date:  2005-04       Impact factor: 3.452

2.  Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux.

Authors:  R C Bell; P Hanna; S Brubaker
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

3.  Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease.

Authors:  M Fein; M P Ritter; T R DeMeester; S Oberg; J H Peters; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

4.  The effect of hiatal hernia on gastroesophageal reflux disease and influence on proximal and distal esophageal reflux.

Authors:  Nurten Savas; Ulku Dagli; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2008-01-17       Impact factor: 3.199

5.  Upright, supine, or bipositional reflux: patterns of reflux do not affect outcome after laparoscopic Nissen fundoplication.

Authors:  S M Cowgill; S Al-Saadi; D Villadolid; D Arnaoutakis; D Molloy; A S Rosemurgy
Journal:  Surg Endosc       Date:  2007-05-24       Impact factor: 4.584

6.  The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms.

Authors:  J H Peters; T R DeMeester; P Crookes; S Oberg; M de Vos Shoop; J A Hagen; C G Bremner
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

7.  Patients with upright reflux have less favorable postoperative outcomes after laparoscopic antireflux surgery than those with supine reflux.

Authors:  Emily R Winslow; Margaret M Frisella; Nathaniel J Soper; Ray E Clouse; Mary E Klingensmith
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

Review 8.  Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.

Authors:  Salvatore Tolone; Giorgia Gualtieri; Edoardo Savarino; Marzio Frazzoni; Nicola de Bortoli; Manuele Furnari; Giuseppina Casalino; Simona Parisi; Vincenzo Savarino; Ludovico Docimo
Journal:  World J Gastrointest Surg       Date:  2016-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.